Clinical Trials
2 trialsNCT05572463 2022-11-18
A Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metastatic Cutaneous Melanoma
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1/2 Withdrawn
NCT04296786 2020-03-05
Sintilimab Plus Chidamide in the Treatment of Relapsed and Refractory Cutaneous T-cell Lymphoma: a Multicenter Phase II Study
Peking Union Medical College Hospital
Phase 2 Unknown